Good Research Practices for Comparative Effectiveness Research: Approaches to Mitigate Bias and Confounding in the Design of Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report—Part II
Emily R. Cox(Express Scripts Holding Company (United States)), Michael L. Johnson(University of Houston), Bradley C. Martin(University of Arkansas for Medical Sciences), Uwe Siebert(Harvard University), Tjeerd van Staa(Utrecht University), Edeltraut Garbe(Leibniz Institute for Prevention Research and Epidemiology - BIPS)
Cited by 309
Related Papers
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
|Osteoporosis International|2007|1.2k
Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation
|New England Journal of Medicine|2007|714
Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data
|BMJ|2017|525
Systematic Review: Agranulocytosis Induced by Nonchemotherapy Drugs
|Annals of Internal Medicine|2007|476
A Meta-Analysis of the Association of Fracture Risk and Body Mass Index in Women
|Journal of Bone and Mineral Research|2013|470